651 filings
Page 5 of 33
DEFA14A
fhl5n5yen wbe7
28 Apr 22
Additional proxy soliciting materials
4:07pm
8-K
rnzjo
31 Mar 22
Departure of Directors or Certain Officers
4:11pm
8-K
4gqt5
24 Feb 22
Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:14pm
8-K
ggcf9varhaz c54x
15 Feb 22
Vaxart Appoints Edward Berg as Senior Vice President and General Counsel
4:02pm
8-K
vo3kq0uw0c7
1 Dec 21
Vaxart Announces Acquisition of Second GMP Manufacturing Facility
4:00pm
8-K
dq9tejp2y9 bar3
4 Nov 21
Vaxart Provides Business Update and Reports Third Quarter 2021 Financial Results
4:06pm
8-K
65bvvmao s2m
21 Sep 21
Entry into a Material Definitive Agreement
4:18pm
8-K/A
8e5hgc
16 Sep 21
Entry into a Material Definitive Agreement
2:42pm
424B5
eo2 7u9sqx
16 Sep 21
Prospectus supplement for primary offering
12:00am
424B5
tg6t9ihbfeevu8b18
15 Sep 21
Prospectus supplement for primary offering
9:47pm
8-K
e98lxt8i
15 Sep 21
Entry into a Material Definitive Agreement
9:47pm
8-K
hish6uyrt tr7ou
23 Aug 21
Vaxart Announces Highly Regarded Biotech Executive Julie M. Cherrington, Ph.D., Joins Board of Directors
4:23pm
8-K
dmzy4
5 Aug 21
Vaxart Provides Business Update and Reports Second Quarter 2021 Financial Results
4:08pm
8-K
v6zq9i
2 Aug 21
Results of Operations and Financial Condition
4:11pm
8-K
25br5p wh2l
20 Jul 21
Changes in Registrant's Certifying Accountant
12:00am